Eurizon Capital SGR S.p.A. Purchases Shares of 322,328 Healthpeak Properties, Inc. $DOC

Eurizon Capital SGR S.p.A. purchased a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 322,328 shares of the real estate investment trust’s stock, valued at approximately $5,185,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DOC. Integrated Wealth Concepts LLC boosted its stake in Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after purchasing an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after purchasing an additional 63,930 shares in the last quarter. Woodline Partners LP boosted its stake in Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after purchasing an additional 17,279 shares in the last quarter. Brown Advisory Inc. boosted its stake in Healthpeak Properties by 3.1% during the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after purchasing an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd bought a new position in Healthpeak Properties during the 2nd quarter valued at $3,117,000. 93.57% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on DOC shares. Robert W. Baird increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Citigroup increased their price target on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Scotiabank increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Finally, UBS Group increased their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $19.38.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.23% of the stock is owned by insiders.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $19.01 on Tuesday. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $20.27. The stock has a fifty day moving average of $17.76 and a 200-day moving average of $17.33. The company has a market capitalization of $13.10 billion, a PE ratio of 59.40, a price-to-earnings-growth ratio of 2.43 and a beta of 1.05. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same quarter in the prior year, the firm earned $0.46 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be issued a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.4%. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.